IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

SOLDOVIERI, Maria Virginia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.160
EU - Europa 1.693
AS - Asia 219
SA - Sud America 16
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 4.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.147
IE - Irlanda 629
IT - Italia 166
UA - Ucraina 165
FI - Finlandia 148
CN - Cina 146
AT - Austria 144
SE - Svezia 118
DE - Germania 112
BE - Belgio 84
GB - Regno Unito 64
IN - India 26
FR - Francia 16
RU - Federazione Russa 16
CA - Canada 12
IR - Iran 11
JP - Giappone 11
NL - Olanda 10
AU - Australia 9
EU - Europa 8
BR - Brasile 7
ES - Italia 6
SG - Singapore 6
CL - Cile 5
IL - Israele 5
HK - Hong Kong 4
NZ - Nuova Zelanda 4
AR - Argentina 3
MD - Moldavia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
MY - Malesia 2
SA - Arabia Saudita 2
TR - Turchia 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ID - Indonesia 1
KZ - Kazakistan 1
MX - Messico 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 4.111
Salva come PNG Salva come JPEG
Città #
Dublin 626
Chandler 459
Jacksonville 385
Ann Arbor 163
Vienna 144
Wilmington 126
Helsinki 111
Woodbridge 91
New York 90
Brussels 84
San Mateo 73
Beijing 71
Princeton 57
Rome 50
Boardman 34
Houston 34
Molise 27
Dearborn 24
Ashburn 21
Falls Church 15
Redwood City 15
Los Angeles 13
Napoli 13
Nanjing 12
Hefei 10
Kunming 10
Mountain View 9
Norwalk 9
Auburn Hills 8
Toronto 7
Augusta 6
Clearwater 6
Falkenstein 6
London 5
Milan 5
Naples 5
San Francisco 5
Shenyang 5
Tokyo 5
Hong Kong 4
Leawood 4
Mumbai 4
Paris 4
Pune 4
Roseto Degli Abruzzi 4
Sacramento 4
Saint-maur-des-fossés 4
Seattle 4
São Paulo 4
Washington 4
Andover 3
Auckland 3
Baotou 3
Berlin 3
Bologna 3
Caserta 3
Centro 3
Chisinau 3
Gaillimh 3
Haikou 3
Jinan 3
Madrid 3
Noicattaro 3
Taiyuan 3
Tappahannock 3
Wuhan 3
Yekaterinburg 3
Zhengzhou 3
Ardabil 2
Athens 2
Birmingham 2
Brixen 2
Cassino 2
Chengdu 2
Guangzhou 2
Hebei 2
Kuala Lumpur 2
Lappeenranta 2
Melbourne 2
Monmouth Junction 2
Montreal 2
Nanchang 2
Pescara 2
Redmond 2
Riyadh 2
San Vito Chietino 2
Santarcangelo di Romagna 2
St Petersburg 2
Stockholm 2
Almaty 1
Almere Stad 1
Amsterdam 1
Apo 1
Bangalore 1
Barcelona 1
Bari 1
Bisaccia 1
Bloomington 1
Borås 1
Boston 1
Totale 2.990
Salva come PNG Salva come JPEG
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 135
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 125
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 102
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 102
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 99
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 96
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 92
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 91
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 90
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 89
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 89
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 88
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 88
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 87
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 86
Autism and developmental disability caused by KCNQ3 gain-of-function variants 85
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 84
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 84
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 83
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 82
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 82
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 81
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 80
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 79
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 79
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 78
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene 76
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 76
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 75
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 74
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 73
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 72
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 72
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 70
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 68
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 67
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 65
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 64
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 64
Addressing the use of PDIF-CN(2) molecules in the development of n-type organic field-effect transistors for biosensing applications 60
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 60
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 60
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 59
null 58
The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability. 58
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 55
Gating consequences of charge neutralization of arginine residues in the S-4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 55
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 52
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 47
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 47
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 44
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 44
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 43
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 39
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 37
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 36
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 35
The long and winding road to personalized medicine in KCNMA1-linked channelopathies revealed by novel variants associated with the Liang-Wang syndrome 34
Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 33
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 31
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 30
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 6
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 3
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 2
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 1
Totale 4.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 16 4
2019/2020544 3 5 46 45 52 32 127 45 91 34 8 56
2020/2021495 20 50 1 72 73 42 69 3 62 10 79 14
2021/2022402 13 65 4 13 42 44 12 35 75 43 26 30
2022/20231.807 225 80 30 181 133 169 11 79 780 59 42 18
2023/2024298 72 40 16 7 8 95 10 17 12 11 10 0
Totale 4.301